Can AI save this consumer packaged foods company from the relentless margin pressure?

Lilly has seen dramatic sales growth over the last couple of years from its injectable, dual GLP-1/GIP agonist obesity ...

A review of some of the content highlights from LCGC International in 2025.

McKesson posts a strong fiscal second quarter, lifts full-year EPS outlook, and shows how specialty growth and automation are reshaping its earnings power.

The Danish drugmaker said the drug will be available from today at prices starting from $149 per month for cash purchasers.

Peptide therapeutics have progressed from insulin discovery to GLP-1 class molecules, revolutionizing diabetes treatment and ...

Algorized, the pioneer in people-sensing foundational models, and KUKA, one of the global leaders in intelligent automation, are introducing a breakthrough that redefines human?robot collaboration: ...

The year also reinforced a long-standing strength of Indian pharma: its ability to scale through strategic consolidation.

Welcome to a new year! And to this week’s Food Exec Brief, your strategic intelligence roundup covering AI’s transition from ...

From autonomous robotaxis, to blind box and nostalgia marketing here are 5 of the most innovative business moves and trends ...

Explore MiniMed Group, Inc.'s upcoming IPO, market position in diabetes devices, and key financial risks. Click for this MMED coverage ahead of its public offering.

Jess Loren remembers loving the taste of Cap'n Crunch cereal. Coca-Cola. Snickers bars. But now, instead of a sweetness, "they taste bland," she says. Flavors are noticeably muted since she started a ...